Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
NCT06209359Phase 1Recruiting
- Sponsor
- Yale University
- Start
- Jul 2024
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in heart failure (HF) and Diuretic resistance comparing Ammonium chloride with Placebo (2 arms). Primary endpoint: Change of distal sodium reabsorption at Day 1. Started Jul 2024; status: recruiting.
02
Drugs
03
Conditions
heart failure (HF)Diuretic resistance
Beyond the preview
Go deeper on NCT06209359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06209359.